Literature DB >> 10636123

Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies.

P B Andersson1, E Yuen, K Parko, Y T So.   

Abstract

OBJECTIVE: Because diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) frequently is missed or delayed, we looked for electrodiagnostic features that raise suspicion of the disorder by making comparisons with two more common diseases that mimic it electrophysiologically: chronic inflammatory demyelinating polyneuropathy (CIDP) and diabetic polyneuropathy.
METHODS: A retrospective review of the neuromuscular laboratory database was performed.
RESULTS: Nine HNPP subjects, 22 with CIDP and 49 with diabetic polyneuropathy. Of all the HNPP nerves studied, abnormally slow sensory nerve conduction velocity (SNCV) was found in 93%, prolonged distal motor latencies (DML) in 78%, slow motor nerve conduction velocity in 31%, and prolonged F-wave latencies in 90%. Mean SNCV for HNPP was 85.6%+/-10.6% of the lower limit of normal and significantly slower than for CIDP (114.3%+/-20.1%; p<0.0001) or diabetes (108.1%+/-14.8%; p<0.0001). Excluding the carpal tunnel site from the analysis did not alter this observation: Mean DML were more prolonged in HNPP, even without median nerve data in the analysis (118.5%+/-31.0% of the upper limit of normal), than in CIDP (103.2%+/-31.6%; p<0.05) or diabetes (86.3%+/-18.3%; p<0.0001). Mean HNPP motor nerve conduction velocity was within normal limits.
CONCLUSIONS: According to findings, hereditary neuropathy with liability to pressure palsies (HNPP) has a distinctive background polyneuropathy independent of superimposed entrapment neuropathy. It is characterized by diffuse sensory nerve conduction velocity (SNCV) slowing and prolongation of distal motor latencies with relatively infrequent and minor reduction of motor nerve conduction velocities. This indicates disproportionate distal conduction slowing in the disorder.

Entities:  

Mesh:

Year:  2000        PMID: 10636123     DOI: 10.1212/wnl.54.1.40

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  A review of genetic counseling for Charcot Marie Tooth disease (CMT).

Authors:  Carly E Siskind; Seema Panchal; Corrine O Smith; Shawna M E Feely; Joline C Dalton; Alice B Schindler; Karen M Krajewski
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

Review 2.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Age associated axonal features in HNPP with 17p11.2 deletion in Japan.

Authors:  H Koike; M Hirayama; M Yamamoto; H Ito; N Hattori; F Umehara; K Arimura; S Ikeda; Y Ando; M Nakazato; R Kaji; K Hayasaka; M Nakagawa; S Sakoda; K Matsumura; O Onodera; M Baba; H Yasuda; T Saito; J Kira; K Nakashima; N Oka; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

Review 4.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

5.  Electrophysiological comparison between males and females in HNPP.

Authors:  Fiore Manganelli; Chiara Pisciotta; Raffaele Dubbioso; Valerio Maruotti; Rosa Iodice; Francesca Notturno; Lucia Ruggiero; Carmine Vitale; Maria Nolano; Antonino Uncini; Lucio Santoro
Journal:  Neurol Sci       Date:  2012-12-04       Impact factor: 3.307

Review 6.  Inherited peripheral neuropathies.

Authors:  Mario A Saporta; Michael E Shy
Journal:  Neurol Clin       Date:  2013-03-05       Impact factor: 3.806

7.  Hereditary neuropathy with liability to pressure palsies: case report and discussion.

Authors:  Marc J Grossman; Joseph Feinberg; Edward F DiCarlo; Sherri B Birchansky; Scott W Wolfe
Journal:  HSS J       Date:  2007-09

8.  Entrapment in anti myelin-associated glycoprotein neuropathy.

Authors:  Catharina G Faber; Nicolette C Notermans; John H J Wokke; Hessel Franssen
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

Review 9.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

Review 10.  The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management.

Authors:  J Chad Hoyle; Michael C Isfort; Jennifer Roggenbuck; W David Arnold
Journal:  Appl Clin Genet       Date:  2015-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.